1. Home
  2. MYFW vs CERS Comparison

MYFW vs CERS Comparison

Compare MYFW & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

N/A

Current Price

$24.99

Market Cap

244.6M

Sector

Finance

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.32

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYFW
CERS
Founded
2002
1991
Country
United States
United States
Employees
321
N/A
Industry
Major Banks
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
244.6M
276.0M
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
MYFW
CERS
Price
$24.99
$2.32
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$24.25
$4.00
AVG Volume (30 Days)
28.3K
1.6M
Earning Date
01-22-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
391.62
N/A
EPS
1.28
N/A
Revenue
$95,514,000.00
$199,191,000.00
Revenue This Year
$15.96
$25.31
Revenue Next Year
$13.77
$9.50
P/E Ratio
$19.65
N/A
Revenue Growth
19.92
13.03
52 Week Low
$17.52
$1.12
52 Week High
$28.00
$2.96

Technical Indicators

Market Signals
Indicator
MYFW
CERS
Relative Strength Index (RSI) 45.50 51.15
Support Level $24.37 $2.44
Resistance Level $25.47 $2.54
Average True Range (ATR) 1.20 0.17
MACD -0.24 -0.04
Stochastic Oscillator 37.16 37.19

Price Performance

Historical Comparison
MYFW
CERS

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: